ICM
SCPL

Invenomic Capital Management’s SciPlay Corporation Class A Common Stock SCPL Stock Holding History

Invenomic Capital Management’s Portfolio SCPL Stock Details SCPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100,177
Closed -$1.29M – 194
2022
Q1 		$1.29M Buy
+100,177
New +$1.27M 0.14% 122

Other funds holding SCPL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
RL
Ruffer LLP London, United Kingdom $2.44B AUM 44.75% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Invenomic Capital Management's SCPL Position: Q2 2022 in Review

Invenomic Capital Management sold out of SciPlay Corporation Class A Common Stock (SCPL) in Q2 2022, closing a stake of 100,177 shares — an estimated $1.29M sold.

Invenomic Capital Management first reported a position in SCPL in Q1 2022 and held it in 1 quarter. The position peaked at $1.29M in Q1 2022. 102 funds tracked by Wall St. Rank hold SCPL as of Q2 2022.

  • Invenomic Capital Management reported no remaining SciPlay Corporation Class A Common Stock position as of Q2 2022 after selling out during the quarter.
  • Invenomic Capital Management sold 100,177 SciPlay Corporation Class A Common Stock shares in Q2 2022, an estimated $1.29M.
  • Invenomic Capital Management first reported a position in SciPlay Corporation Class A Common Stock in Q1 2022 and held it in 1 quarter.
  • Invenomic Capital Management's SciPlay Corporation Class A Common Stock position peaked at $1.29M in Q1 2022.
  • 102 funds tracked by Wall St. Rank held SciPlay Corporation Class A Common Stock as of Q2 2022.

Based on Invenomic Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.